Control Bionics Limited (ASX:CBL)

Control Bionics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	2.08	0.59	0.98	0.94	5.21
Short-Term Investments	-	0.08	0.08	0.06	0.06
Cash & Short-Term Investments	2.08	0.67	1.06	0.99	5.27
Cash Growth	208.76%	-36.46%	6.76%	-81.18%	-57.31%
Accounts Receivable	1.35	1.4	1.28	1.31	1.17
Other Receivables	-	0.49	0.83	0.45	0.31
Receivables	1.35	1.89	2.11	1.95	2.19
Inventory	0.45	0.41	0.4	0.8	0.92
Prepaid Expenses	-	-	-	0.15	0.22
Other Current Assets	0.3	0.2	0.19	-	-
Total Current Assets	4.18	3.17	3.76	3.9	8.61
Property, Plant & Equipment	0.36	0.84	1.22	0.72	0.73
Long-Term Investments	-	0.34	-	-	-
Other Intangible Assets	4.51	3.88	4.05	4.11	4.07
Other Long-Term Assets	-	-	-	-	0.02
Total Assets	9.05	8.23	9.03	8.73	13.44

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	1.83	1.39	1.02	0.69	0.43
Accrued Expenses	0.27	0.59	0.44	0.53	0.62
Short-Term Debt	0.49	0.09	0.52	-	0.05
Current Portion of Leases	0.13	0.21	0.11	0.13	0.11
Current Unearned Revenue	-	0.27	0.32	0.22	0.15
Total Current Liabilities	2.72	2.55	2.4	1.56	1.36
Long-Term Leases	-	0.13	0.34	-	0.12
Pension & Post-Retirement Benefits	0.02	0.04	0.02	0.02	0.03
Total Liabilities	2.73	2.72	2.76	1.58	1.51

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	46.14	40.37	35.15	30.24	29.27
Retained Earnings	-42.65	-35.39	-29.28	-23.37	-17.73
Comprehensive Income & Other	2.82	0.53	0.39	0.27	0.39
Shareholders' Equity	6.31	5.51	6.27	7.15	11.92
Total Liabilities & Equity	9.05	8.23	9.03	8.73	13.44

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	0.62	0.44	0.96	0.13	0.28
Net Cash (Debt)	1.46	0.24	0.1	0.86	4.99
Net Cash Growth	514.50%	144.73%	-88.77%	-82.69%	-59.56%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.06
Filing Date Shares Outstanding	410.27	294.61	199.29	102.41	90.48
Total Common Shares Outstanding	410.27	294.61	199.29	90.48	86.91
Working Capital	1.47	0.62	1.36	2.34	7.25
Book Value Per Share	0.02	0.02	0.03	0.08	0.14
Tangible Book Value	1.81	1.63	2.22	3.04	7.85
Tangible Book Value Per Share	0.00	0.01	0.01	0.03	0.09
Machinery	-	1.8	1.87	1.4	1.06
Construction In Progress	-	0	-	0	0.05
Leasehold Improvements	-	0.04	0.04	0.04	0.04

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 28, 2026

Data Sources Report a data error